Posts in tag

migraine


Debbie Rigby rounds up the latest in research news Interprofessional collaboration within general practice teams following the inclusion of non-dispensing pharmacists This survey explored collaboration between pharmacists and health professionals …

Debbie Rigby rounds up the latest in research news Clinical Impact of medication reviews with follow-up in cardiovascular older patients in primary care This cluster-randomised controlled trial was conducted in …

Migraine attacks occurring around menstruation are more severe and harder to treat. This article looks at the presentation and types of menstrual migraine, as well as common medications used for …

Pharmacists can make a difference to the burden of headache and migraine, given research shows GPs aren’t adequately trained and 50% of patients haven’t even been properly diagnosed. The 2020-21 …

Debbie Rigby rounds up the latest in research news Multiple short courses of corticosteroids in children Short courses of oral steroids (less than two weeks) in children are very unlikely …

Debbie Rigby rounds up the latest in research news Migraine management Drugs can be used to treat acute migraine, or they can be used prophylactically to reduce the frequency and …

Migraine treatment and immediate release ibuprofen set to be downscheduled, but no change to status of another high profile medicine  The migraine treatment eletriptan is to move to Schedule 3 …

Downscheduling of migraine treatments begins on 1 Feb The Pharmacy Guild of Australia welcomed the confirmed decision to down-schedule the migraine treatments sumatriptan and zolmitriptan to S3, or pharmacist-only, medicines. …

Scheduling decisions see migraine treatments move to Pharmacist Only status, while liquid paracetamol S2 sales to be restricted from mid-year Proposed medicines scheduling changes will see the migraine treatments Sumatriptan …

Karalyn Huxhagen looks at the debilitating condition of vestibular migraine, or migraine-associated vertigo There are many forms of migraine. The term can be used ‘loosely’ by patients presenting to the …

Uncertainty for migraine patients and pharmacists is likely to persist as Novartis pulls PBS application for Aimovig This week Novartis decided to no longer proceed with a third Aimovig (erenumab) …

A new report into migraine has found that GPs are still prescribing a lot of codeine, with more than half of sufferers obtaining the medicine to treat their condition The …